Contact: Customized Assays
Emily is an experienced scientist (13+ years) with a background within nanotechnology and molecular microbiology. She is skilled in strategic planning and management of research projects and is responsible for development of drug testing services within cytotoxicity and antimicrobial activity. Her interests span basic research, innovation, methods development, and commercialization.
James brings over 20 years of scientific expertise in organic chemistry, bacteriology, and molecular biology. He excels in strategic research leadership and managing complex preclinical research programs. As a key driver of the company’s drug testing services, James provides strategic guidance on customized testing approaches and leads the development of innovative platforms, including novel organoid infection models and cytotoxicity assessment assays.